Alessandro Russo, MD, PhD

Medical Oncology Unit, Department of Onco-Hematology, Papardo Hospital, Messina, Italy

Dr. Russo is a board-certified medical oncologist with interest in thoracic malignancies, immunotherapy and liquid biopsies.

Dr. Russo degreed as M.D. at the University of Messina (Italy) and there he completed his residency in Medical Oncology. He had his PhD in 2019 in Medical and Surgical Biotechnologies at the University of Messina, with a research project on the role of liquid biopsies as predictive biomarkers to immune checkpoint inhibitors in advanced non-small cell lung cancer (NSCLC). During his PhD, Dr. Russo joined as Visiting Researcher the Division of Thoracic Medical Oncology and Early Clinical Trials at the University of Maryland Medical Center, Greenebaum Comprehensive Cancer Center (Baltimore, USA).

From February 2020 he joined the Medical Oncology Unit of the Papardo Hospital (Messina, Italy) as medical oncologist, with focus on thoracic malignancies.

He is member of several national and international scientific societies, including the International Association for the Study of Lung Cancer (IASLC), the Italian Association of Thoracic Oncology (AIOT), the Italian Association of Medical Oncology (AIOM) and the European Society for Medical Oncology (ESMO). Dr. Russo took part to the Executive Board of the Sicilian Section of the Italian Association of Medical Oncology (AIOM) for the years 2015-2019.

Dr. Russo is co-author of several publications in peer-reviewed international journals, four book chapters, and he is actively involved in clinical research in advanced NSCLC and liquid biopsy